CARIVALAN 6.25mg / 5mg tablets medication leaflet

C07FX06 carvedilol + ivabradine • Cardiovascular system | Beta blocking agents, other combinations

Carvedilol and ivabradine are used together for the treatment of chronic heart failure in patients with elevated heart rates despite optimal therapy. This combination combines the effects of a beta-blocker (carvedilol) and a sinus node inhibitor (ivabradine), helping to reduce heart rate and improve cardiac function.

Carvedilol helps reduce the workload on the heart by relaxing blood vessels and lowering blood pressure, while ivabradine reduces heart rate by acting on the sinus node. This combination is particularly indicated for patients who cannot tolerate high doses of beta-blockers.

The medications are taken orally as directed by a doctor, and the dosage is adjusted based on the patient's response. Regular monitoring is essential to assess the effectiveness of the treatment and detect potential side effects.

Side effects may include dizziness, fatigue, bradycardia, low blood pressure, and, in rare cases, visual disturbances. Patients should inform their doctor of any unusual symptoms or adverse reactions.

General data about CARIVALAN 6.25mg / 5mg

Substance: carvedilol + ivabradine

Date of last drug list: 01-06-2025

Commercial code: W63601003

Concentration: 6.25mg / 5mg

Pharmaceutical form: tablets

Quantity: 56

Product type: generic

Price: 114.27 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: LES LABORATOIRES SERVIER INDUSTRIE - FRANTA

Holder: LES LABORATOIRES SERVIER - FRANTA

Number: 9781/2017/03

Shelf life: 2 years

Concentrations available for carvedilol + ivabradine

12.5mg/5mg, 12.5mg/7.5mg, 25mg/5mg, 25mg/7.5mg, 6.25mg/5mg, 6.25mg/7.5mg